Medicosnext

The growing evidence suggests that coronavirus, which was originally thought to impact only the respiratory tract, can cause damages to other vital organs like the heart, kidneys, liver, and the brain. Though the studies on long-term effects of COVID-19 are still scant, and the medical fraternity doesn’t know whether one …

In the case of a viral infection, the body’s first protective action is a non-specific innate response, where macrophages, neutrophils, and dendritic cells slow the progress of the pathogen and may even prevent any symptoms from occurring. The next protective action is an adaptive response (cellular immunity), with the body …

Artificial organs Initially considered to be a ground-breaking technology for its ability to regenerate skin cells for skin draughts for burn victims, bio-printing is an emerging medical technology that is now giving way to even more exciting possibilities. Bio-printing can be used to create blood vessels and synthetic ovaries (perhaps even …

Based on early data from the first-ever clinical trial in humans in the US, genetically editing a cancer patient’s immune cells using CRISPR/Cas9 technology and infusing them back into the patient seems to be safe and feasible. Three participants in the trial (two with multiple myeloma and one with sarcoma) …

In ongoing lawsuits in the USA, claims have been made that Zantac and ranitidine contain unacceptable levels of the cancer-causing chemical N-Nitrosodimethylamine, or NDMA. Lawyers have charged that NDMA contamination causes stomach, liver, and bladder cancer. In September 2019, an online pharmacy had alerted the U.S. Food and Drug Administration …

Once upon a time, getting a blood transfusion was a highly a risky affair, because some people receiving donated blood were apt to get chronic hepatitis (liver inflammation) from an unknown, mysterious disease. And, although the Hepatitis A and Hepatitis B viruses were discovered by the mid-1960s, in 1972, Prof. …

Words by Sargam Raja Mahat, PharmD; Digbijay Raja Mahat, PhD; Yug Bijay Mahat, MD; and Subhas Bijay Mahat, MBBS Introduction Our world has been battling against Severe Acute Respiratory Syndrome Coronavirus – 2 (SARS-CoV-2), the cause of Coronavirus Disease – 19 (COVID-19), as this pandemic has spurred a global health …

Pfizer and BioNTech’s COVID-19 vaccine has been authorized for emergency use in the United Kingdom, which has ordered 40 million doses, enough for 20 million people, since two doses are required for each individual. The government expects to receive 10 million doses before the end of the year. The developers …

The pioneer medial educationist talks to Medicos Next about his career and medical education in Nepal as he retires from his post at Nepal Medical College after over 24 years of service in July this year.   Dr. Shekhar Babu Rizyal, Former Director Medical Education Dept., Nepal Medical College, did …

Siberia’s Vector Research Center has claimed that all volunteers vaccinated by its COVID-19 vaccine, EpiVacCorona, developed antibodies, although the first two phases of testing involved only 100 volunteers. The center reported, “Clinical studies have shown that antibodies were detected in 100% of the volunteers immunized with the EpiVacCorona vaccine, Most …